The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis

Biomarkers that assess treatment response for patients with the autoimmune disorder, myasthenia gravis (MG), have not been evaluated to a significant extent. We hypothesized the pro-inflammatory cytokine, osteopontin (OPN), may be associated with variability of response to glucocorticoids (GCs) in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yanchen, Li, Hai-Feng, Sun, Liang, Kusner, Linda L., Wang, Shuhui, Meng, Yunxiao, Zhang, Xu, Hong, Yu, Gao, Xiang, Li, Yao, Kaminski, Henry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450020/
https://www.ncbi.nlm.nih.gov/pubmed/28620344
http://dx.doi.org/10.3389/fneur.2017.00230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450020/
https://www.ncbi.nlm.nih.gov/pubmed/28620344
http://dx.doi.org/10.3389/fneur.2017.00230

Ejemplares similares